FMR LLC 13D and 13G filings for aTyr Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | aTyr Pharma, Inc. ATYR | FMR LLC | 8,784,009 14.999% | 4,432,602 (+101.87%) | Filing |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | aTyr Pharma, Inc. ATYR | FMR LLC | 4,351,407 14.999% | 182,806 (+4.39%) | Filing |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | aTyr Pharma, Inc. ATYR | FMR LLC | 4,168,601 14.999% | 2,492,721 (+148.74%) | Filing |
| 2021-07-12 12:07 pm Purchase | 2021-07-09 | 13G | aTyr Pharma, Inc. ATYR | FMR LLC | 1,675,880 10.432% | 91,196 (+5.75%) | Filing |
| 2021-04-12 1:05 pm Purchase | 2021-04-09 | 13G | aTyr Pharma, Inc. ATYR | FMR LLC | 1,584,684 9.897% | 56,866 (+3.72%) | Filing |
| 2021-02-08 10:15 am Purchase | 2021-02-05 | 13G | aTyr Pharma, Inc. ATYR | FMR LLC | 1,527,818 14.999% | 1,036,369 (+210.88%) | Filing |